Lineage Cell Therapeutics (LCTX) Inventory Average (2011 - 2015)
Lineage Cell Therapeutics (LCTX) posted quarterly Inventory Average of $130500.0 for Q4 2015, down 49.77% year-over-year from $259783.5 in Q4 2014, and down 53.14% quarter-over-quarter from $278500.0 in Q3 2015.
Lineage Cell Therapeutics (LCTX) Inventory Average (2011 - 2015) Analysis & Trends
Lineage Cell Therapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $130500.0 for Q4 2015.
- In Q4 2015, Inventory Average fell 49.77% year-over-year to $130500.0; the TTM figure through Dec 2015 stood at $130500.0 (down 49.77% YoY), while the FY2015 annual figure was $133500.0, down 39.96% from the prior year.
- Inventory Average for Q4 2015 stood at $130500.0, down from $278500.0 in the prior quarter.
- The five-year high for Inventory Average was $298154.0 in Q2 2015, with the low at $53020.0 in Q1 2012.
- The 5-year median for Inventory Average is $91425.8 (2013), against an average of $143926.5.
- The sharpest annual moves came in 2014 and 2015: Inventory Average soared 322.38% in 2014, then tumbled 49.77% in 2015.
- Lineage Cell Therapeutics' Inventory Average stood at $56144.5 in 2011, then declined by 0.0% to $56142.0 in 2012, then surged by 113.59% to $119913.0 in 2013, then surged by 116.64% to $259783.5 in 2014, then plunged by 49.77% to $130500.0 in 2015.
- Business Quant data shows LCTX's Inventory Average at $130500.0 in Q4 2015, $278500.0 in Q3 2015, and $298154.0 in Q2 2015.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Lineage Cell Therapeutics | 270.61 Mn | 212.77 Mn | 1.07 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | 130,500.00 |
| Sep 30, 2015 | 278,500.00 |
| Jun 30, 2015 | 298,154.00 |
| Mar 31, 2015 | 282,654.00 |
| Dec 31, 2014 | 259,783.50 |
| Sep 30, 2014 | 255,748.00 |
| Jun 30, 2014 | 247,258.50 |
| Mar 31, 2014 | 207,641.00 |
| Dec 31, 2013 | 119,913.00 |
| Sep 30, 2013 | 62,938.50 |
| Jun 30, 2013 | 58,540.00 |
| Mar 31, 2013 | 53,825.50 |
| Dec 31, 2012 | 56,142.00 |
| Sep 30, 2012 | 55,993.00 |
| Jun 30, 2012 | 54,942.00 |
| Mar 31, 2012 | 53,020.00 |
| Dec 31, 2011 | 56,144.50 |
| Sep 30, 2011 | 58,979.00 |